Wednesday, March 29, 2023


Biotechnology News Magazine


Dr Matt Cahill Appointed Chief Operating Officer of Qu Biologics

Dr Matt Cahill was a founding employee of Deep Genomics – a biotechnology company focused on the application of artificial intelligence in drug development. He played a central role in crafting and operationalizing the company’s strategy, helped build the executive team, and led a variety of functions including finance, legal, HR, and business development. During his tenure, the company formed its first Pharma partnerships and raised more than USD$200M through multiple rounds of financing.

IO Biotech Announces Appointment of Devin Smith as General Counsel

Devin Smith joins IO Biotech bringing over two decades of legal and compliance experience in the life science industries.

SK bioscience Appoints New Executives to Accelerate New Growth Strategies

With recruitment of global talent and capabilities accumulated during the COVID-19 pandemic, SK bioscience will continue to achieve sustainable growth.

Optibrium appoints Steve Yemm as Chief Commercial Officer

Steve Yemm will manage the commercial team to drive forward global sales, customer success and marketing activities, as well as working within Optibrium’s executive team to develop commercial strategy.

EDP Biotech Announces New Hire Sam Libby to Lead Rapid Company Growth and Expansion Opportunities

Sam Libby joins EDP Biotech Corporation as Head of Mergers & Acquisitions and Corporate Development to expand investments and create new corporate relationship opportunities as the company grows.

Solid Biosciences Appoints Kevin Tan, CFA, as Chief Financial Officer

Kevin Tan brings more than 20 years of financial experience to Solid, most recently as CFO at Selecta Biosciences.